Effective Reduction of SARS-CoV-2 RNA Levels Using a Tailor-Made Oligonucleotide-Based RNA Inhibitor

In only two years, the coronavirus disease 2019 (COVID-19) pandemic has had a devastating effect on public health all over the world and caused irreparable economic damage across all countries. Due to the limited therapeutic management of COVID-19 and the lack of tailor-made antiviral agents, findin...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Veronika Nemethova, Petra Mazancova, Michal Selc, Kristina Jakic, Lucia Uhelska, Boglarka Nemethova, Alexandra Poturnayova, Lubos Drgona, Andrea Babelova, Filip Razga
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI AG 2022-03-01
Cyfres:Viruses
Pynciau:
SARS-CoV-2
COVID-19
RNA levels
oligonucleotide-based RNA inhibitor
RdRp
Mynediad Ar-lein:https://www.mdpi.com/1999-4915/14/4/685
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg